Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial-Reference-Cited by-同舟云学术

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial

Published:2019-11 Issue:11 Volume:58 Page:1062-1078
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

Jensen Karsten Gjessing,Correll Christoph U.,Rudå Ditte,Klauber Dea Gowers,Decara Marie Stentebjerg,Fagerlund Birgitte,Jepsen Jens Richardt Møllegaard,Eriksson Frank,Fink-Jensen Anders,Pagsberg Anne Katrine

Funder

National Research Council

Research Foundation

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference70 articles.

1. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London;Chang;PLoS One,2011

2. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries;Laursen;PLoS One,2013

3. Mortality and causes of death in schizophrenia in Stockholm County, Sweden;Osby;Schizophr Res,2000

4. Mortality among persons with schizophrenia in Sweden: an epidemiological study;Fors;Nordic J Psychiatry,2007

5. Life expectancy and cardiovascular mortality in persons with schizophrenia;Laursen;Curr Opin Psychiatry,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis;The Lancet Child & Adolescent Health;2024-07

2. Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review;International Clinical Psychopharmacology;2024-06-14

3. Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis;Psychiatry Research;2024-04

4. Antipsychotic Medication Use In Medicaid-Insured Children Decreased Substantially Between 2008 And 2016;Health Affairs;2023-07-01

5. Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system;CNS Neuroscience & Therapeutics;2023-04-10